Partial-onset Seizures Clinical Trial
Official title:
A Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures
The purpose of this study is to confirm the efficacy and safety of perampanel compared to placebo in patients with refractory partial-onset seizures
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00232596 -
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
|
Phase 3 | |
| Recruiting |
NCT04015141 -
A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy
|
Phase 2 | |
| Completed |
NCT01832038 -
Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures
|
Phase 3 | |
| Completed |
NCT02192814 -
Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures
|
Phase 3 | |
| Completed |
NCT00235755 -
Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
|
Phase 3 | |
| Completed |
NCT02736162 -
Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy
|
N/A | |
| Completed |
NCT02124564 -
A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures
|
Phase 3 | |
| Completed |
NCT04230044 -
A Study to Evaluate the Safety and Efficacy of Fycompa® (Perampanel) as Add-on Therapy in Participants With Epilepsy
|